![]() |
|
|
|
|
1
4th November 15:32
External User
Posts: 1
|
IMO they want to deliver something via swine flu vax (over and above the
profits). This could be squalene http://www.whale.to/v/squalene.html which is behind gulf war syndrome, and tween 80 which is linked to infertility http://www.whale.to/v/tween_80.html, and/or some implant thingy such as nanoparticles http://www.whale.to/vaccine/nano_particles.html All flu is due to industrial and electro pollution http://www.whale.to/a/toxic_air_h.html http://www.whale.to/b/elf6.html combined with lack of vitamin D (for starters) http://www.whale.to/a/vitamin_d.html, plus wrong diet http://www.whale.to/a/nutrition.html and other poisons http://www.whale.to/v/poisons.html Flu vaccination is a long running racket http://www.whale.to/vaccines/flu.html Swine flu is no exception, I doubt it even exists as an entity, they create the market by using the yearly flu statistics, helped by the 200 year old diagnosis ploy using labs where they can fiddle anything 'I have been doing locums in lots of different practices . In some Primary Care Trusts, they are remunerating GPs for their extra swine flu work by looking at how many consultations are logged as 'swine flu', so I have been told to enter any cold, upper-respiratory tract infection , fever etc as swine flu, and some GPs are going back in their patients records since the swine flu started and re-labelling the reason for the consultation. Is it any wonder there are so many cases?' ---[2009 Aug] Calling Big Pharma's Bluff - Swine Flu Misfires in the UK By John Stone http://www.whale.to/vaccine/stone495.html See diagnosis ploy http://www.whale.to/vaccines/ploy3.html If you study history eg Swine flu 1976 http://www.whale.to/vaccine/swine.html you can see the template, either way you would be pretty naive to trust them If you look at infectious scares you can see the racket going back years http://www.whale.to/a/infectious_scares.html A simple example was the 1953 'epidemic' http://www.whale.to/a/1953_uk.html which was used to hide toxic coal. Swine flu vax roundup http://www.whale.to/vaccine/swine_flu_vax.html john |
|
|
|
|
4
4th November 15:33
External User
Posts: 1
|
http://www.gavialliance.org/media_ce...entavalent.php
<quote> 18 million Indian children to receive life-saving five-in-one vaccine One of the millions of Indian children set to benefit from the pentavalent vaccine. Copyright: UNICEF/2005/Pallava Bagla US$165 million grant from GAVI will kick off massive introduction of new vaccine. Geneva, 11 August 2009 –More than 18 million children in India will be immunised with a pentavalent five-in-one vaccine thanks to funding worth US$ 165 million from the GAVI Alliance, a public-private partnership which brings together all key players in immunisation including the Indian government, the World Health Organization, UNICEF, donors, industry and the Hib Initiative. A decision by the GAVI Alliance’s Executive Committee in Geneva announced today paves the way for the introduction of the combination vaccine in India, where some 27 million children are born each year. This is the first phase of a national roll-out which will start in 10 states. The decision to approve the funding was communicated to Indian Health Minister Ghulam Nabi Azad by GAVI Alliance Deputy CEO Helen Evans on Monday 10 August. Ninety percent of world's poorest children “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4" GAVI CEO, Dr. Julian Lob-Levyt The pentavalent vaccine protects against five potential killers -- diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (often known as Hib) which causes some severe forms of pneumonia and meningitis. Children need to be vaccinated three times before they can be considered fully immunised. While children in all countries are routinely immmunised against diphtheria, tetanus, pertussis and increasingly hepatitis B, the introduction of this pentavalent vaccine in India, will mean that now more than 90% of the world’s poorest children will be vaccinated against Hib. Globally, Hib kills more than 370,000 children under five every year; nearly 20% of these children die in India. Survivors are often permanently paralyzed, deafened or brain damaged. Routine introduction of Hib vaccine has been proven to prevent the majority of severe bacterial meningitis and up to one third of life-threatening cases of bacterial pneumonia, the leading infectious cause of death in children worldwide. Critical step “The introduction of the pentavalent vaccine in India is a critical step in our government’s efforts to protect all Indian children from deadly diseases,” said India’s Health Minister Ghulam Nabi Azad. “We are glad to be working with the GAVI Alliance to turn this long-held vision into a reality for millions of families. I am extremely thankful to GAVI for assistance given for pentavalent vaccine.” “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4, which aims to reduce child mortality by two-thirds by 2015,” said Dr. Julian Lob-Levyt. “With such a significant number of pneumonia deaths occurring in India, we are pleased to see India recognising the importance of adding protection against Hib while continuing to work on strengthening routine immunisation." One of largest-ever GAVI grants In one of its largest-ever single grants, GAVI will fund the first two years of pentavalent vaccine introduction in India. In the first year, the pentavalent vaccine will reach more than 10 million children in 10 states -- about 40 percent of India’s total number of babies born each year. By funding the introduction of the pentavalent vaccine, GAVI will equip India to expand its use in the rest of the country. Pneumonia control strategy “Introduction of Hib vaccine in India will save thousands of children’s lives,” said Panna Choudhury, President of the Indian Academy of Pediatrics. “Routine use of Hib vaccine is an essential piece of a comprehensive pneumonia control strategy to reduce the disease's terrible burden on children.” "No child should die or suffer from this preventable disease,” said Dr. Mathuram Santosham, executive committee member of the Hib Initiative at Johns Hopkins Bloomberg School of Public Health. “Hib vaccine is a safe, effective intervention that has been used for more than nearly 20 years in developed countries. Where used routinely in countries such as Kenya, Uganda and the Gambia, it has been proven to virtually eliminate Hib disease.” Pentavalent vaccine is now available from Indian suppliers and is expected to be used both in children in India and around the world. With increasing demand, this indigenous supply will play an important role in saving children’s lives. The GAVI Alliance The GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, the Bill & Melinda Gates Foundation and other private philanthropists. GAVI support consists of providing life-saving vaccines and strengthening health systems. Since 2000, 213 million children have been vaccinated and 3.4 million premature deaths averted thanks to GAVI-funded programmes. For more information, please visit: www.gavialliance.org The Hib Initiative The Hib Initiative unites experts from Johns Hopkins Bloomberg School of Public Health, the London School of Hygiene and Tropical Medicine, the World Health Organization, and the Centers for Disease Control and Prevention (CDC) and provides technical, coordination and communication support to countries making decisions regarding the use of Hib vaccine. The Hib Initiative is supported by a 4-year grant from the GAVI Alliance. The Hib vaccine is being used or will soon be used in at least 62 developing countries eligible for support from the GAVI Alliance. For more information, visit www.hibaction.org For more information, please contact: Dan Thomas GAVI Alliance Tel: +41.22.909.6524 Mobile: +41 79 251 8581 dthomas@gavialliance.org Ariane Leroy GAVI Alliance Tel: +41.22.909.6521 Mobile: +41 79 340 1878 aleroy@gavialliance.org Rose Reis Hib Initiative Tel: +1- 410-502-4283 rreis@jhsph.edu Dr. Sunil D. Khaparde India’s Ministry of Health & Family Welfare Mobile: + 91-9958097015 </quote> .. Only someone who is either damned stupid or a plain criminal would call a scientific research and scientific facts fanatic. Ralph Paul Autrey, Jr., by the way, is a criminal stalker. He publicly insulting others as "beast", "satan", "female genital", "Satan," "Satan Whore", "Nazi", "Idiot!", "Insane!", "Possessed!", "Get an exorcism!", and so on. All the time long... An impressive list of hate crime committed by Ralph Paul Autrey Jr. The attorneys of state have homework to do. -- How a sect kills YOUR children http://www.pharmamafia.com |
|
|
7
4th November 15:33
External User
Posts: 1
|
To save the lives of children is NOT fanatic. http://www.gavialliance.org/media_ce...entavalent.php
<quote> 18 million Indian children to receive life-saving five-in-one vaccine One of the millions of Indian children set to benefit from the pentavalent vaccine. Copyright: UNICEF/2005/Pallava Bagla US$165 million grant from GAVI will kick off massive introduction of new vaccine. Geneva, 11 August 2009 –More than 18 million children in India will be immunised with a pentavalent five-in-one vaccine thanks to funding worth US$ 165 million from the GAVI Alliance, a public-private partnership which brings together all key players in immunisation including the Indian government, the World Health Organization, UNICEF, donors, industry and the Hib Initiative. A decision by the GAVI Alliance’s Executive Committee in Geneva announced today paves the way for the introduction of the combination vaccine in India, where some 27 million children are born each year. This is the first phase of a national roll-out which will start in 10 states. The decision to approve the funding was communicated to Indian Health Minister Ghulam Nabi Azad by GAVI Alliance Deputy CEO Helen Evans on Monday 10 August. Ninety percent of world's poorest children “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4" GAVI CEO, Dr. Julian Lob-Levyt The pentavalent vaccine protects against five potential killers -- diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (often known as Hib) which causes some severe forms of pneumonia and meningitis. Children need to be vaccinated three times before they can be considered fully immunised. While children in all countries are routinely immmunised against diphtheria, tetanus, pertussis and increasingly hepatitis B, the introduction of this pentavalent vaccine in India, will mean that now more than 90% of the world’s poorest children will be vaccinated against Hib. Globally, Hib kills more than 370,000 children under five every year; nearly 20% of these children die in India. Survivors are often permanently paralyzed, deafened or brain damaged. Routine introduction of Hib vaccine has been proven to prevent the majority of severe bacterial meningitis and up to one third of life-threatening cases of bacterial pneumonia, the leading infectious cause of death in children worldwide. Critical step “The introduction of the pentavalent vaccine in India is a critical step in our government’s efforts to protect all Indian children from deadly diseases,” said India’s Health Minister Ghulam Nabi Azad. “We are glad to be working with the GAVI Alliance to turn this long-held vision into a reality for millions of families. I am extremely thankful to GAVI for assistance given for pentavalent vaccine.” “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4, which aims to reduce child mortality by two-thirds by 2015,” said Dr. Julian Lob-Levyt. “With such a significant number of pneumonia deaths occurring in India, we are pleased to see India recognising the importance of adding protection against Hib while continuing to work on strengthening routine immunisation." One of largest-ever GAVI grants In one of its largest-ever single grants, GAVI will fund the first two years of pentavalent vaccine introduction in India. In the first year, the pentavalent vaccine will reach more than 10 million children in 10 states -- about 40 percent of India’s total number of babies born each year. By funding the introduction of the pentavalent vaccine, GAVI will equip India to expand its use in the rest of the country. Pneumonia control strategy “Introduction of Hib vaccine in India will save thousands of children’s lives,” said Panna Choudhury, President of the Indian Academy of Pediatrics. “Routine use of Hib vaccine is an essential piece of a comprehensive pneumonia control strategy to reduce the disease's terrible burden on children.” "No child should die or suffer from this preventable disease,” said Dr. Mathuram Santosham, executive committee member of the Hib Initiative at Johns Hopkins Bloomberg School of Public Health. “Hib vaccine is a safe, effective intervention that has been used for more than nearly 20 years in developed countries. Where used routinely in countries such as Kenya, Uganda and the Gambia, it has been proven to virtually eliminate Hib disease.” Pentavalent vaccine is now available from Indian suppliers and is expected to be used both in children in India and around the world. With increasing demand, this indigenous supply will play an important role in saving children’s lives. The GAVI Alliance The GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, the Bill & Melinda Gates Foundation and other private philanthropists. GAVI support consists of providing life-saving vaccines and strengthening health systems. Since 2000, 213 million children have been vaccinated and 3.4 million premature deaths averted thanks to GAVI-funded programmes. For more information, please visit: www.gavialliance.org The Hib Initiative The Hib Initiative unites experts from Johns Hopkins Bloomberg School of Public Health, the London School of Hygiene and Tropical Medicine, the World Health Organization, and the Centers for Disease Control and Prevention (CDC) and provides technical, coordination and communication support to countries making decisions regarding the use of Hib vaccine. The Hib Initiative is supported by a 4-year grant from the GAVI Alliance. The Hib vaccine is being used or will soon be used in at least 62 developing countries eligible for support from the GAVI Alliance. For more information, visit www.hibaction.org For more information, please contact: Dan Thomas GAVI Alliance Tel: +41.22.909.6524 Mobile: +41 79 251 8581 dthomas@gavialliance.org Ariane Leroy GAVI Alliance Tel: +41.22.909.6521 Mobile: +41 79 340 1878 aleroy@gavialliance.org Rose Reis Hib Initiative Tel: +1- 410-502-4283 rreis@jhsph.edu Dr. Sunil D. Khaparde India’s Ministry of Health & Family Welfare Mobile: + 91-9958097015 </quote> .. -- How a sect kills YOUR children http://www.pharmamafia.com |
|
|
8
4th November 15:34
External User
Posts: 1
|
To defame vaccination, as does John Scudamore, is a crime.
Vaccination saves lives. http://www.gavialliance.org/media_ce...entavalent.php <quote> 18 million Indian children to receive life-saving five-in-one vaccine One of the millions of Indian children set to benefit from the pentavalent vaccine. Copyright: UNICEF/2005/Pallava Bagla US$165 million grant from GAVI will kick off massive introduction of new vaccine. Geneva, 11 August 2009 –More than 18 million children in India will be immunised with a pentavalent five-in-one vaccine thanks to funding worth US$ 165 million from the GAVI Alliance, a public-private partnership which brings together all key players in immunisation including the Indian government, the World Health Organization, UNICEF, donors, industry and the Hib Initiative. A decision by the GAVI Alliance’s Executive Committee in Geneva announced today paves the way for the introduction of the combination vaccine in India, where some 27 million children are born each year. This is the first phase of a national roll-out which will start in 10 states. The decision to approve the funding was communicated to Indian Health Minister Ghulam Nabi Azad by GAVI Alliance Deputy CEO Helen Evans on Monday 10 August. Ninety percent of world's poorest children “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4" GAVI CEO, Dr. Julian Lob-Levyt The pentavalent vaccine protects against five potential killers -- diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (often known as Hib) which causes some severe forms of pneumonia and meningitis. Children need to be vaccinated three times before they can be considered fully immunised. While children in all countries are routinely immmunised against diphtheria, tetanus, pertussis and increasingly hepatitis B, the introduction of this pentavalent vaccine in India, will mean that now more than 90% of the world’s poorest children will be vaccinated against Hib. Globally, Hib kills more than 370,000 children under five every year; nearly 20% of these children die in India. Survivors are often permanently paralyzed, deafened or brain damaged. Routine introduction of Hib vaccine has been proven to prevent the majority of severe bacterial meningitis and up to one third of life-threatening cases of bacterial pneumonia, the leading infectious cause of death in children worldwide. Critical step “The introduction of the pentavalent vaccine in India is a critical step in our government’s efforts to protect all Indian children from deadly diseases,” said India’s Health Minister Ghulam Nabi Azad. “We are glad to be working with the GAVI Alliance to turn this long-held vision into a reality for millions of families. I am extremely thankful to GAVI for assistance given for pentavalent vaccine.” “India’s important and far-sighted decision to introduce the pentavalent vaccine will bring the country and the world significantly closer to achieving Millennium Development Goal 4, which aims to reduce child mortality by two-thirds by 2015,” said Dr. Julian Lob-Levyt. “With such a significant number of pneumonia deaths occurring in India, we are pleased to see India recognising the importance of adding protection against Hib while continuing to work on strengthening routine immunisation." One of largest-ever GAVI grants In one of its largest-ever single grants, GAVI will fund the first two years of pentavalent vaccine introduction in India. In the first year, the pentavalent vaccine will reach more than 10 million children in 10 states -- about 40 percent of India’s total number of babies born each year. By funding the introduction of the pentavalent vaccine, GAVI will equip India to expand its use in the rest of the country. Pneumonia control strategy “Introduction of Hib vaccine in India will save thousands of children’s lives,” said Panna Choudhury, President of the Indian Academy of Pediatrics. “Routine use of Hib vaccine is an essential piece of a comprehensive pneumonia control strategy to reduce the disease's terrible burden on children.” "No child should die or suffer from this preventable disease,” said Dr. Mathuram Santosham, executive committee member of the Hib Initiative at Johns Hopkins Bloomberg School of Public Health. “Hib vaccine is a safe, effective intervention that has been used for more than nearly 20 years in developed countries. Where used routinely in countries such as Kenya, Uganda and the Gambia, it has been proven to virtually eliminate Hib disease.” Pentavalent vaccine is now available from Indian suppliers and is expected to be used both in children in India and around the world. With increasing demand, this indigenous supply will play an important role in saving children’s lives. The GAVI Alliance The GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, the Bill & Melinda Gates Foundation and other private philanthropists. GAVI support consists of providing life-saving vaccines and strengthening health systems. Since 2000, 213 million children have been vaccinated and 3.4 million premature deaths averted thanks to GAVI-funded programmes. For more information, please visit: www.gavialliance.org The Hib Initiative The Hib Initiative unites experts from Johns Hopkins Bloomberg School of Public Health, the London School of Hygiene and Tropical Medicine, the World Health Organization, and the Centers for Disease Control and Prevention (CDC) and provides technical, coordination and communication support to countries making decisions regarding the use of Hib vaccine. The Hib Initiative is supported by a 4-year grant from the GAVI Alliance. The Hib vaccine is being used or will soon be used in at least 62 developing countries eligible for support from the GAVI Alliance. For more information, visit www.hibaction.org For more information, please contact: Dan Thomas GAVI Alliance Tel: +41.22.909.6524 Mobile: +41 79 251 8581 dthomas@gavialliance.org Ariane Leroy GAVI Alliance Tel: +41.22.909.6521 Mobile: +41 79 340 1878 aleroy@gavialliance.org Rose Reis Hib Initiative Tel: +1- 410-502-4283 rreis@jhsph.edu Dr. Sunil D. Khaparde India’s Ministry of Health & Family Welfare Mobile: + 91-9958097015 </quote> .. -- How a sect kills YOUR children http://www.pharmamafia.com |
|
|
|